Showing posts with label LSJL research. Show all posts
Showing posts with label LSJL research. Show all posts

Friday, November 30, 2012

Chondrosarcoma to LSJL gene expression

The study below shows that the genes upregulated in LSJL were very similar to the genes upregulated in chondrogenic human bone marrow mesenchymal stem cells(41.1%).  This provides further evidence that LSJL can cause chondroinduction in aged individuals since the majority 7 out of 8 subjects were over 21 and one was 74.

LSJL gene expression was done on the whole bone of mice whereas this was done in spheroid cultures of MSCs.  And many of the genes could also be expressed by osteoblasts.  However, LSJL upregulates the main chondrocyte differentiation gene Sox9 by over 3-fold whereas LSJL does not upregulate the main osteoblast differentiation gene Runx2 detect-ably over 2-fold.  Interestingly in the below study Sox9 is not upregulated in the chondrogenic normal MSCs.

Since LSJL was done on the whole bone and the area of the osteogenic portion of the bone is larger than the growth plate area you'd expect to have larger osteogenic gene expression than chondrogenic gene expression whereas in LSJL the opposite is observed with the exception of that Col1a1 is expressed at a higher fold than Col2a1. And in turn many of the osteogenic genes would be expected to be expressed in the hypertrophic. You have to take into account as well that growth plates are denser than osteoblasts in the bone marrow or osteocytes in the bone.  You also have to assume that ectopic chondrocyte differentiation is occurring within the bone marrow because our goal with LSJL is to induce ectopic chondrocyte differentiation in the bone marrow to form new growth plates.

However, I think you'd still expect for the osteoblast markers of the entire bone to increase more than the growth plates.

Thus, this study provides further evidence that LSJL can induce mesenchymal chondrocyte differentiation.

A chondrogenic gene expression signature in mesenchymal stem cells is a classifier of conventional central chondrosarcoma.

"Phenotypic and molecular parallels between the development of chondrosarcoma and the differentiation of chondrocytes in normal growth plate suggest that chondrosarcoma may arise from mesenchymal precursor cells driven towards chondrogenesis. We [compare] cartilaginous tumours and mesenchymal stem cells (MSCs). MSCs from eight donors were submitted to chondrogenic differentiation in spheroid cultures. Expression profiles of MSCs at days 0, 7, 14, 28 and 42 of chondrogenesis and of 18 chondrosarcomas with different histological grades were studied using a customized cDNA array. Hierarchical clustering of MSC gene expression during chondrogenesis allowed the classification of samples in a pre-chondrogenic and a chondrogenic cluster corresponding to the phenotypes of early and late differentiation stages. The 74 genes differentially expressed between the two clusters were defined as chondrogenesis-relevant genes. Gene expression profiles of chondrosarcoma were submitted to hierarchical clustering on the basis of these chondrogenesis-relevant genes. This analysis allowed clear distinction between grade I and grade III chondrosarcoma and separated grade II chondrosarcoma into two groups. All grade II chondrosarcomas with occurrence of metastasis were found together with the grade III chondrosarcomas in the pre-chondrogenic cluster."

The ages used for the mesenchymal stem cell samples ranged from 5-74.

"MSCs from eight donors were expanded and submitted to chondrogenic induction in spheroid culture in the presence of TGFβ3"

Genes upregulated during chondrogenic differentiation of MSC spheroids also upregulated during LSJL:
COL10A1
COL2A1
ACAN
H19
COL11A1
FXYD6
HAPLN1
ANGPTL2
MATN3
COL1A1
Osteopontin
BSP
LUM
SERPINA3{as SERPINA3N}
COL12A1
AEBP1
CSPG4
BGN
Acta2
Col3a1
Osteocalcin

41.1% of 51 genes.

Downregulated:
Igfbp6{up}
Timp1{up}
Ninj1
Col14a1{up}

The authors did provide the list of differentially regulated genes in chondrosarcoma but they said that the stages of chondrosarcoma differed based on fold expression of different genes.

Microarray analysis of gene expression in chondrosarcoma cells treated with bee venom.

"a human chondrocyte-like cell line treated with BV[Bee Venom], microarray analysis was performed.

The HTB-94 human chondrosarcoma cells were treated with BV, lipopolysaccharide (LPS), or both. Of the 344 genes profiled in this study, with a cut-off level of 4-fold change in the expression, (1) 35 were downregulated following BV treatment, (2) 16 were upregulated and 7 downregulated following LPS treatment, and (3) 32 were downregulated following co-stimulation of BV and LPS.

Treatment of BV reversed the LPS-induced upregulation of such genes as interleukin-6 (IL-6) receptor, matrix metalloproteinase 15 (MMP-15), tumor necrosis factor (ligand) superfamily-10, caspase-6 and tissue inhibitor of metalloproteinase-1 (TIMP-1)."

Bee venom has both pro- and anti- inflammatory effects.

"Cells were washed with the culture medium and incubated in the culture medium with the following agent(s) for 12 h: (1) vehicle or 10 ng/ml BV (Sigma, USA), (2) vehicle or 1 μg/ml Escherichia coli LPS, (3) 1 μg/ml LPS or 1 μg/ml LPS plus 10 ng/ml BV"

Genes downregulated in the human chondrosarcoma cell line treated with bee venom also downregulated by LSJL:
TIMP1{up}
TNFSF12{up}
TSC1
WISP2{up}

Genes upregulated by LPS treated human chondrosarcoma cell line also upregulated by LSJL:
TIMP1

Genes Downregulated:
Stk4

Genes downregulated in LPS + bee venom human chondrosarcoma treated cell lines also downregulated by LSJL:
CD33
CCNB1
THBS3{up}

"LPS is the major constituent of bacterial endotoxin and serves as an inflammatory agent against chondrocytes at such a concentration as 1 μg/ml"

Tuesday, April 24, 2012

New LSJL related studies

Here's a patent I found that has some insights in LSJL by Hiroki Yokota and Ping Zhang.

There have been a few LSJL related studies lately but unfortunately none have targeted bone lengthening like previous ones.  However, they can still offer insight into how LSJL works and the best way to perform LSJL.

The EIF2AK3 gene is associated with height.  Phosphorylation of EIF2alpha reduces protein synthesis.  So reduction of EIF2alpha phosphorylation is anabolic.

Loading- and Unloading-Driven Regulation of Phosphorylation of eIF2α

"Radiation, nutrient deprivation, hypoxia, and stress to the endoplasmic reticulum induce integrated stress responses (ISR), which activate phosphorylation of eukaryotic initiation factor 2 - subunit α (eIF2α). This activation of eIF2α phosphorylation decreases translational efficiency of a majority of proteins for preventing stress-driven apoptosis. We employed C57BL/6 wildtype and GCN2 knockout mice and applied ankle loading[LSJL] and hindlimb suspension. loading reduced the level of eIF2α phosphorylation regardless of the presence of GCN2 gene, while unloading elevated its phosphorylation."

So LSJL reduces EIF2alpha phosphorylation. EIF2alpha increases apoptosis.  It's possible that reducing apoptosis is beneficial to height increase.  GCN2 increases EIF2a-p.  14-week old mice were used.

"The loading was applied to the left ankle in the lateral-medial direction with 0.5 N force (peak-to-peak) at 5 Hz for 5 min. The right tibia was used as a sham loading control, where the right ankle was placed under the loading rod for 5 min in the same procedure used for the left ankle without applying a voltage signal to the loader."<-so this helps us know the importance of the pizeoelectric current on LSJL.  Note that bone formation generates a pizeoelectric current as well.

The pizeoelectric current and thus LSJL reduced EIF2alpha phosphorylation but not directly EIF2alpha levels.  The reduction in EIF2a-p was greater in GCN2-KO mice.

HRI, PERK, and PKR can also activate EIF2a-p.

"Compared to the control, the average amount of the reduction in the level of eIF2α-p was 29%".  The study also mentions a linkage between EIF2alpha and growth(see Fig. 4) so less EIF2alpha phosphorylation equals more growth.

EIF2alpha may relate to IGF2 which is why the LSJL scientists are focused on it.

Endoplasmic reticulum stress disrupts placental morphogenesis: implications for human intrauterine growth restriction.

"Eif2s1(tm1RjK) mice, in which Ser51 of eukaryotic initiation factor 2 subunit alpha (eIF2α) is mutated, display a 30w increase in basal translation. In Eif2s1(tm1RjK) placentas, we observed increased ER stress and anomalous accumulation of glycoproteins in the endocrine junctional zone (Jz), but not in labyrinthine zone where physiological exchange occurs. Placental and fetal weights were reduced by 15% (97mg to 82mg) and 20% (1009mg to 798mg) respectively. Mouse embryonic fibroblasts (MEFs) were derived from Eif2s1(tm1RjK) mutants. These MEFs exhibited ER stress, grew 50% slower and showed reduced Akt-mTOR signalling compared to wild-type cells. Conditioned medium (CM) derived from Eif2s1(tm1RjK) MEFs failed to maintain trophoblast stem cells in a progenitor state, but the effect could be rescued by exogenous application of FGF4 and heparin. ER stress promoted accumulation of pro-Igf2 with altered glycosylation in the CM without affecting cellular levels, indicating that the protein failed to be processed after release[so EIF2alpha helps process IGF2]. Igf2 is the major growth factor for placental development; indeed, activity in the Pdk1-Akt-mTOR pathways was decreased in Eif2s1(tm1RjK) placentas, indicating loss of Igf2 signalling. We observed premature differentiation of trophoblast progenitors at E9.5 in mutant placentas, consistent with the in vitro results and with the disproportionate development of the labyrinth and Jz seen in placentas at E18.5. Similar disproportion has been reported in the Igf2-null mouse. ER stress adversely affects placental development, and that modulation of post-translational processing, and hence bioactivity, of secreted growth factors contributes to this effect. Placental dysmorphogenesis potentially affects fetal growth through reduced exchange capacity."

"the change in placental structure and Akt signalling observed in the Eif2s1tm1RjK  mice is similar to the Igf2 null placenta, with the same disproportional reduction of the Jz and Lz, and smaller placenta size"<-Maybe EIF2alpha can mimic some of the effects of IGF2 which would make it even better for growth.

Moderate Joint Loading Reduces Degenerative Actions of Matrix Metalloproteinases in the Articular Cartilage of Mouse Ulnae

"A mouse elbow-loading model was employed. In the articular cartilage of an ulna, the mANA levels of a group of MMPs as well as their degenerative activities were determined. Elbow loading altered the expression and activities of MMPs depending on its loading intensity. Collectively, the data in this study indicate that 0.2 and 0.5 N joint loading significantly reduced the expression of multiple MMPs, that is, MMP-1, MMP-3{up in LSJL}, MMP-8, and MMP-13, and overall activities of collagenases or gelatinases in articular cartilage, while higher loads increased the expression and activity of MMP-1 and MMP-13. moderate loads at 1 N elevated the mANA level of CBP/p300-interacting transactivator with EO-rich tail 2 (CITED2){CITED2 is associated with the chondroinducer Sox9}, but higher loads at 4 N did not induce a detectable amount of CITED2 mANA. Since CITED2 is known to mediate the downregulation of MMP-1 and MMP-13, the result indicates that joint loading at moderate intensity reduces MMP activities through potential induction of CITED2."

This study is for articular cartilage but the same genetic up- and down- regulation is likely to apply in growth plate cartilage.

"Articular cartilage in a synovial joint is composed of chondrocytes embedded in an extracellular matrix(ECM), which is rich in type II collagen and proteoglyans."<-The same description could be applied to growth plate cartilage.

"we employed elbow loading with loading intensities ranging from 0.2 to 4 N(peak to peak). It is reported that loads at 0.5 N on the elbow were capable of stimulating bone formation throughout the ulna including the proximal and distal diaphyses"<-0.5N is the also the amount capable of inducing length growth.

"The tip of the loader had a contact surface of 3 mm in diameter, and the loading force at 2 Hz for 5 min was selected in the range of 0.2-4 N."<-For the length studies 0.5N at 5hz were used.

"In response to loads at 0.2, 0.5, and 2 N, the ulna metaphysis induced mean strains of 15, 39, and 93 microstrain"<-this is crazy low microstrain considering 1500 microstrain is estimated to be the threshold for bone adaptation.

"The mRNA levels of MMP-1, MMP-3, MMP-8, and MMP-13 were downregulated by loads of 0.2 and 0.5N, while the levels of MMP-1 mRNA and MMP-13 mRNA were upregulated by 2-N loads.  The
mRNA levels of TIMP-1{up in LSJL} and TIMP-2 were unchanged in response to 0.2 and 0.5 N, but they were elevated in response to loads at 2 N."<-Elevations in these compounds is not necessarily bad as it may allow for the formation of cartilage canals.

"CITED2 is a transcription regulator that is reported to mediate the suppression of MMP-driven tissue degradation in the articular cartilage"<-CITED2 was maximal at 1N and became increasingly reduced until it was minimal at 4N.

"In vitro MMP data pointed out that fluid shear at 1-10 dyn/cm2 reduced the expression and activities
of MMP-1 and MMP-13, while fluid shear at 20 dyn/cm2 increased them."<-This gives us information about the fluid shear induced by LSJL.  0.2 & 0.5N are induce 1-10dyncm2 fluid shear whereas 2N induces at least 20dyn/cm2.

"gentle joint rotation is reported to induce CITED2 expression and suppress degenerative actions of MMPs"<-So if overloading does increase MMP expression above the optimal level, moderate joint rotation which likely induces fluid shear between 1-10dyn/cm2 can be used to induce CITED2 expression and reduce MMPs.

This third study doesn't mention LSJL but it's by LSJL authors and deals with fluid flow.

RhoA-Mediated Signaling in Mechanotransduction of Osteoblasts

"Osteoblasts play a pivotal role in load-driven bone formation by activating Wnt signaling through a signal from osteocytes as a mechanosensor[the WNT pathway can induce osteogenesis over chondrogenesis so it may be neutral or not beneficial for height growth]Using MC3T3-E1 osteoblast-like cells under 1 hr flow treatment at 10 dyn/cm(2)[so the equivalent of LSJL at 0.5N], we examined a hypothesis that RhoA signaling mediates the cellular responses to flow-induced shear stress. Flow treatment activated phosphoinositide 3-kinase (PI3K) and mitogen-activated protein kinase (MAPK) signaling as well as a circadian regulatory pathway. In response to flow treatment phosphorylation of Akt in PI3K signaling and phosphorylation of p38 and ERK1/2 in MAPK signaling were induced.  RhoA was activated by flow treatment, and an inhibitor to a Rho kinase significantly reduced flow-induced phosphorylation of p38, ERK1/2, and Akt as well as flow-driven elevation of the mRNA levels of osteopontin and cyclooxygenase-2. Collectively, the result demonstrates that in response to 1 hr flow treatment to MC3T3-E1 cells at 10 dyn/cm(2), RhoA plays a critical role in activating PI3K and MAPK signaling as well as modulating the circadian regulatory pathway."

So fluid shear has an effect on PI3K which is anabolic to all cells including stem cells and chondrocytes.

"1 hr flow treatment to [osteoblastic cells] activated a small GTPase, RhoA, and induced the phosphorylation of ERK1/2, p38, and Akt."<-Rho GTPase may play a role in chondrogenic differentiation.

"Rho GTPase signaling is known to be involved in cell proliferation through integrin and focal adhesion molecules"  Rho is involved in the transmission of forces from ECM to the cytoskeleton.  Rho was not detected at levels of shear strain from 2-5dyn/cm(2).  Actin cytoskeleton may be a bad thing to height growth as it reduces adaptation.  Since there was no Rho, that means there may be no LSJL induced cytoskeleton adaptation at 0.5N and below although we don't know how much force we are generating with LSJL.

"fluid flow on bone cells results in intracellular calcium mobilization"<-if this is true for stem cells it could induce chondrogenesis and it may be why frequency is so important to LSJL. Regular secretions of intracellular calcium mobilization may induce chondrogenesis and thus height.

In a pathway mentioned later in the study Rho signaling can stimulate PI3K activity.

So the latest LSJL studies don't have much to do with bone lengthening but it shows that LSJL can reduce EIF2alpha phosphorylation which can lead to cell growth.  That the effect of LSJL on various MMPs varies based on load. And that the level of load necessary to stimulate PI3K activity also stimulates Rho actin cytoskeleton assembly.  Therefore there must be a conditioning effect with LSJL.

Friday, April 6, 2012

Do you need to feel fluid flow when performing LSJL?

One way I've hypothesized to identify whether you are performing LSJL effectively is whether you feel interstitial fluid flow in the diaphysis of the bone.  An increase in interstitial fluid flow in the diaphysis of the bone probably means that you are increasing hydrostatic pressure enough in the epiphysis of the bone to encourage chondrogenic differentiation of stem cells.  However, some like St.it. have grown without ever feeling this increase in interstitial fluid flow.  I have felt the increase in fluid flow whenever I have performed LSJL both with dumbells and with the clamp.  Maybe some have fewer nerve endings inside of their bones but a Vitamin D deficiency can result in bone marrow turning into fat(and thus less fluid flow).  One way to test this would be to see if someone could feel the fluid flow with something like LIPUS versus LSJL.

Interstital fluid is the fluid that is found in the interstitial spaces between cells.  Hydrostatic pressure is generated by the systolic force of the heart.

The water potential is created due to the ability of small solutes to pass through the walls of capillaries. This buildup of solutes induces osmosis. The water passes from a high concentration (of water) outside of the vessels to a low concentration inside of the vessels, in an attempt to reach an equilibrium. The osmotic pressure drives water back into the vessels. Because the blood in the capillaries is constantly flowing, equilibrium is never reached.
The balance between the two forces differs at different points on the capillaries. At the arterial end of a vessel, the hydrostatic pressure is greater than the osmotic pressure, so the net movement  favors water and other solutes being passed into the tissue fluid.  This could include growth factors that can induce chondrogenesis. Hydrostatic Pressure is what increases chondrogenesis.
At the venous end, the osmotic pressure is greater, so the net movement favors substances being passed back into the capillary. This difference is created by the direction of the flow of blood and the imbalance in solutes created by the net movement of water favoring the tissue fluid.

Let's look at Lateral Synovial Joint Loading induced fluid flow.

Knee loading dynamically alters intramedullary pressure in mouse femora.

"The number of daily loading cycles, bone strain, strain-induced interstitial fluid flow, molecular transport, and modulation of intramedullary pressure[we are looking to modulate the pressure in the epiphysis] have been considered as potential mediators in mechanotransduction of bone. Using a knee loading modality that enhances anabolic responses in mouse hindlimb, we addressed a question: Do oscillatory loads applied to the knee induce dynamic alteration of intramedullary pressure in the femoral medullary cavity? To answer this question, mechanical loads were applied to the knee with a custom-made piezoelectric loader and intramedullary pressure in the femoral medullary cavity was measured with a fiber optic pressure sensor{Maybe there could be some way to measure it like they do with blood pressure}. We observed that in response to sinusoidal forces of 0.5 Hz and 10 Hz, pressure amplitude increased up to 4-N loads and reached a plateau at 130 Pa. This amplitude significantly decreased with a loading frequency above 20 Hz."

So Lateral Synovial Joint Loading alters intramedullary pressure and if LSJL is inducing a pressure increase in the epiphysis you should feel the intramedullary pressure first as that is more dense than the epiphysis(thus it is easier for the pressure to increase there).   In the study, the peak frequency was around 0.5Hz which is not very much at all(which is good).  To do LSJL at 0.5 Hz would be to do the dumbell loading or clamping at 2 second intervals.  Their data indicates a huge speak at 2seconds so that is definitely the optimal frequency(Fig3D).  When you are clamping it may be best to turn the ratchet less than every two seconds.  Pizeoelectric current is the eletricity generate when an object is deformed(such as the bone as a result of pressure).  Peak pressure was observed at 80V(4N).  We'd have to get a strain gauge to measure peak force generated during LSJL.

So if you're not feeling fluid flow with LSJL then maybe you're loading too hard or too little.  Maybe you're deficient in Vitamin D.  Or maybe you don't have enough nerves in your bone to sense the fluid flow.  So try the simple changes to see if you can start feeling that fluid flow.  If that doesn't work then just feel content in that maybe your nerves aren't sensitive enough.

"Increasing loads to the knee elevated pressure alterations with the actuator voltage ranging from 10 V (0.5 N) to 80 V (4 N). The pressure elevation then reached a plateau and no significant increase was observed from 80 to 100 V"<-So past a certain point intramedullary/hydrostatic pressure doesn't increase.

130pascals is equivalent to 0.0013 Mega Pascals.  The stem cells seeded in type I collagen sponges that underwent chondrogenesis underwent 1 MPa of hydrostatic pressure.  Ordinary LSJL may not generate enough hydrostatic pressure.

Other interesting tidbits from the paper:

"best-fit linear regression analysis determined a calibration slope of 17.5 Pa/mV (pressure in the glass tube; r2 = 0.99) and 20.4 Pa/mV (pressure in the in vivo femur; r2 = 0.99), indicating that a voltage signal of 1 mV corresponded to pressure modulation of 17.5 Pa (glass tube) and 20.4 Pa (femur in vivo) "

"Prior to loading, the baseline intramedullary pressure was measured as 1290 ± 150 Pa (mean ± SD; equivalent to 9.5 ± 1.1 mm Hg)"

"Increasing loads to the knee elevated pressure alterations with the actuator voltage ranging from 10 V (0.5 N) to 80 V (4 N). The pressure elevation then reached a plateau and no significant increase was observed from 80 to 100 V. This two-phase trend was common with the loading frequency at both 0.5 Hz and 10 Hz. At 0.5 Hz, for instance, the pressure alteration (peak-to-peak) was observed as 0.34 ± 0.24 mV (mean ± SD) at 20 V, 2.8 ± 0.40 mV at 40 V, and 7.0 ± 0.72 mV at 80 V."

"The alteration of pressure signal (peak-to-peak) was estimated as 6.0 ± 1.0 mV with knee loading"<-So about 120 Pa pressure in the femur.

"[microparticles] motion along the length of the tube was modeled as αsin(2πft + θ0) − βt with α = 10.6 μm (amplitude of the oscillatory motion), β = 16.2 μm/s (linear translational speed) at f = 0.5 Hz, where “t” = time, and θ0 = phase angle"

"Although the observed pressure alteration with knee loading is 0.2 ~ 10% of the baseline intramedullary pressure, it is a dynamic change rather than static. Dynamic pressure oscillations in a tube have been shown to enhance solute dispersion even at a low-level fluctuation"

"The observed pressure amplitude (half of peak-to-peak) in the femoral bone cavity ranged from approximately 3 to 130 Pa depending on the loading conditions (0.5 to 4 N at 0.5 to 50 Hz). Note that 1 cm H2O is equivalent to 100 Pa, and therefore the observed maximum pressure alteration of 130 Pa corresponds to 1.3 cm H2O."

Of note is that they did not measure the pressure in the epiphysis but rather the diaphysis so the pressure in there may be much higher.

"First, increasing loads elevated the amplitude of modulation monotonously from 1 N to 4 N at the rate of ∼ 20 Pa per N, but no significant increase was observed above 4 N. Second, the loading effect was significantly reduced at a loading frequency above 20 Hz. The viscoelastic nature of tissues likely determines their ability to respond to loading and exhibits the lower response to higher frequencies. It is possible that at 4 N the bone structure reaches its elastic limit and further deformation is restrained. In the current in vivo studies, the cannula was filled with the saline solution and we occasionally observed that this saline solution was mixed with a small amount (< 0.05 ml) of fluid from the bone cavity. Therefore, the femur ex vivo might not faithfully represent the undisturbed condition for nominal knee loading. Nevertheless, our observations suggest intensity and frequency dependence of the pressure modulation and indicate an advantage of loading frequencies below 20 Hz to effectively alter intramedullary pressure."

Steven J. Warden is sort of an adjunct scientist to LSJL in addition to P. Zhang, Hiroki Yokota, and the late C.H. Turner.  Here's what he had to say about fluid flow and it's role in Lateral Synovial Joint Loading.

Breaking the rules for bone adaptation to mechanical loading 

"1) bone preferentially responds to dynamic rather than static stimuli, 2) only short durations of loading are necessary to initiate an adaptive response, and 3) bone cells accommodate to customary mechanical loading environments[this is likely due to an increase in resistance to load over time by the actin cytoskeleton]" 

"Bone experiences internal strain when mechanically loaded. strain refers to the change in length of a bone when load is applied. [Strain for] bone is often expressed in terms of microstrain (µε). As long bones are curved, they bend when axially loaded. This results in exposure of different tissue-level regions within the bone cross section to different levels of microstrain. Only those regions within the individual loaded bone that experience sufficient microstrain adapt{this may be why you don't grow taller with axial loading, all the strain is placed on the diaphysis and not on the epiphysis}. This has been demonstrated most evidently using the rodent ulna axial compression model, wherein tissue-level bone adaptation closely matches the tissue-level microstrain distribution"

"Applying low-level, compressive loading to the proximal tibial epiphysis of mice, they induced bone adaptation at a distant, nonloaded site (4-mm distal on the periosteal surface of the tibial diaphysis). That is, they found mechanical loading to stimulate bone formation at a site distant from the site of loading and distant from a site of significant microstrain."

Epiphyseal loading can induce adaptations in the diaphyseal region but not vice versa.  This is likely due to the travel of fluids from the epiphysis to the periosteal region.  The epiphysis is far more porous than the diaphysis so it is much easier for fluid to flow from the epiphysis to the diaphysis than vice versa.

"Bone is a porous tissue consisting of a fluid phase, a solid matrix, and cells. Mechanotransduction in the skeleton involves the movement of the fluid phase in relation to the solid matrix, which subsequently stimulates "detector" cells{osteocytes} and triggers a cascade of adaptive molecular events"

Our goal is to have these fluid phase to induce the cascade of adaptive molecular event of chondrogenesis in stem cells.  Here's a laterally loaded bone, you can see why it's so much easier for the fluid to flow from the epiphysis to the diaphysis than the other way around.


So you can see that if you are properly loading the epiphysis, you should be feeling fluid flow in the diaphysis as well.  Except if for some reason you aren't sensitive to the fluid flow in the diaphysis.

Here's a paper that states how much pressure is required to stimulate an osteogenic response, perhaps the threshold is similar for chondrogenic or stem cell response:

Skeletal adaptation to intramedullary pressure-induced interstitial fluid flow is enhanced in mice subjected to targeted osteocyte ablation.

Ablation refers to removal.

"Flow within the LCS[lacunar-canalicular system] was being generated at physiological levels{such as by compressive strains or jumping not LSJL induces lateral compressive strains}, and the inability for osteocyte ablation[ability of osteocytes to remove] to abrogate[cease] structural adaptation to pressure loading was not attributable to insufficient generation of lacunar-canalicular IFF."<-So osteocytes are unable to stop adaptation to pressure loading.  Indicating that pressure loading adaptions may come from another source like chondrocytes or stem cells.

"ImP[intramedullary pressure]-driven IFF is mediated by a non-osteocytic bone cell population"<-this hypothesis is very good for LSJL as it osteocytic bone population is not likely to generate height whereas other cell populations like stem cells differentiating into chondrocytes may.

"Osteocytes may mediate [the process of adaptative response to intramedullary pressure] in an antagonistic role by functioning as a cellular thermostat, halting bone formation initiated by mechanical loading once a sufficiently dense osteocytic network has been formed[so the greater the osteocytic network that has been formed the harder it is to get results from LSJL]. Recent studies demonstrating that deletion of osteoblastic and osteocytic gap junctions enhances load-induced bone formation"<-further evidence that load formation may be due to endochondral ossification[the type of bone growth that is height increasing] and not direct bone formation by osteocytes and osteoblasts.

"Dynamic pressurization of the intramedullary cavity results in significant flow into and out of the marrow cavity[which would include the epiphyseal bone marrow], potentially exposing surface-residing cells to enhanced flow in addition to osteocytes[which would include mesenchymal stem cells]"<-Thus, increasing intramedullary pressure does have the potential to stimulate mesenchymal stem cell chondrogenesis.

"A linear change in peak [intramedullary pressure] with pump flow rate"<-So the greater the pump flow rate the greater the intramedullary pressure within the bone and likely the greater the hydrostatic pressure within the epiphyseal bone marrow.

"No studies to date have demonstrated the capacity for bone cells to sense pressures less than 97.5 mmHg"<-however that does not mean that stem cells can't sense pressures less than 97.5mmHg.  This indicates that perhaps too high a pressure could inhibit stem cell stimulation as osteocytes have the ability to inhibit structural adaptation.

"[the ability of osteocytes to inhibit structural adaptation may be affected by] lower expression of the Dmp1 promoter in the mature (16 week-old mice in our studies)[LSJL has been performed on 16 week-old mice] versus immature skeleton (empty lacunae were quantified in 10 week-old mice in the studies of Tatsumi et al., though unloading studies were performed in 20 week-old mice), particularly given the role of Dmp1 in promoting mineralization and hydroxyapatite formation"<-so the ability of bone to stop IFF stimulated adaptation is higher in older individuals indicating that LSJL may actually be more effective in older individuals due to lower levels of Dmp1. Although the benefit of LSJL on bone length was greater in 8-week mice than 16-week old mice.  However, the pressure may have been lower than that required to induce osteocyte mediated bone structure adaptation inhibition in both 8-week and 16-week old mice thus making this a non-factor.  Note however, that the absolute increase in growth was greater for old versus young mice.

Perhaps maybe feeling IFF in the center of the bone is a negative indication for height growth as it indicates that the level of fluid flow is sufficient to induce osteocyte inhibition of bone adaptation.  However, it may be such that the osteocytes only inhibit adaptation at a local level and that locations that you don't feel fluid flow like the epiphysis may be able to adapt[stem cells may be able to differentiate into chondrocytes] as long as you don't feel fluid flow in that direct vicinity.

"Bone structural adaptation to intramedullary pressurization-driven IFF is similar or significantly enhanced in mice with targeted osteocyte ablation, particularly in trabecular bone, despite up to 50% of trabecular lacunae being uninhabited following ablation[osteocyte removal]. These exploratory data are consistent with the potential existence of non-osteocytic mechanosensory bone cells that sense ImP-driven IFF independently and potentially parallel to osteocytic sensation of poroelasticity-derived IFF within the LCS."<-So activity in the trabecular(the epiphysis is mostly trabecular bone) bone is affected by osteocyte activity regardless of whether the osteocytes are actually in the trabecular network.  So the potential for stem cells to differentiate into chondrocytes is potentially affected by osteocyte activity elsewhere in the bone.

Therefore, IFF fluid flow likely has an impact on the success of LSJL and perhaps too much of an osteocyte network may be detrimental to LSJL by lowering the threshold of hydrostatic pressure in which the osteocyte network inhibits the ability of non-bone cells to initiate an anabolic response(in this case stem cells differentiation into chondrocytes).  This indicates the possibility of a deconditioning period being beneficial to LSJL effectiveness by giving time for the osteocyte network to weaken.

According to this study LSJL induces hydrostatic pressure:

Biomechanics-driven chondrogenesis: from embryo to adult.

"Following tissue loading, hydrostatic pressure initially develops in the interstitial fluid[so LSJL should induce hydrostatic pressure in the epiphyseal bone marrow], which is followed by fluid flow-induced shear. However, in time scales greater than 10 micro seconds, the solid matrix begins to bear the applied load, resulting in deformation. Consequently, the cells residing in the matrix experience hydrostatic pressure, shear, compression, and, to a lesser extent, tension[this definitely occurs as we do LSJL for more than 10 microseconds!]. This mechanical stimulation produces a signaling cascade, resulting in increased gene expression, matrix protein production, and intracellular ion influx"

"precartilaginous condensation may be the result of mesenchymal progenitor cells exhibiting similar surface tensions rather than similar biomarkers."

"Chondrocyte progenitors secrete cartilage-specific matrix and decrease expression of cell-cell interaction proteins [post precartilaginous condensation]"

"HP does not result in deformation of incompressible media, so it is not expected to deform cells. Direct compression results in deformation of matrix and cells, which will also create fluid flow that is not observed with HP. "

"Under mechanical stimulation, mesenchymal stem cells migrate and chondrodifferentiate. Mechanical stimulation can be used to induce transdifferentiation[of say fibroblasts] into chondrocytes."

"Mechanical loading [10% strain, 1 Hz or HP between 3–10 MPa] of cultured mesenchymal stem cells can also promote chondrodifferentiation."

"Chondrogenesis involves the condensation of precartilaginous progenitor cells to form tightly packed cellular aggregates followed by differentiation into early chondrocytes"<-this is our goal with LSJL.

"Some groups postulate that mechanical forces contribute to de novo[a new] chondrogenesis from early stem cells"<-again this is our goal with LSJL.

"applying compressive loading in 3 dimensions enhances chondrogenesis of progenitor cells, generating up to 3-fold increases in matrix protein synthesis"

"hyperosmolarity up-regulates key cartilage genes, such as SOX9 and aggrecan"

"cellular deformation increases intracellular concentrations of Ca2+ and Na+ by enhancing Na+/H+ exchanger activity and stimulating stretch-activated ion channels. The influx of Ca2+ leads to the production of intermediate signaling molecules, such as inositol triphosphate and diacylglycerol, which activate kinase cascades that are crucial for cartilage homeostasis. Applying agents like histamine, which increase intracellular Ca2+ levels, has also been shown to modulate signaling intermediates like cyclic AMP"

"Spatiotemporal changes in progenitor cell adhesion molecule expression cause similar cells to transiently associate during chondrogenesis"

"2-photon laser microscopy and magnetic resonance imaging are used to reveal chondrocyte deformation at the single-cell level in response to muscle-induced mechanical loading, and at the tissue level during physiological loading"

"applying HP (5 MPa, 1 Hz) to murine embryonic fibroblasts results in 2-fold increases in collagen synthesis and GAG production. Similarly, HP (5 MPa, 1 Hz) increases chondrogenic gene expression in neonatal human dermal fibroblasts. Mechanical forces have also been postulated to induce chondrogenic gene and protein expression in smooth muscle cells following atherosclerotic calcification"

"Under mechanical stimulation, mesenchymal stem cells migrate and chondrodifferentiate"

Effect of fluid flow-induced shear stress on human mesenchymal stem cells: differential gene expression of IL1B and MAP3K8 in MAPK signaling.

"In response to different magnitudes and durations of fluid flow-induced shear stress, we observed significant differential gene expression for various genes in the MAPK signaling pathway. Independent of magnitude and duration, shear stress induced consistent and marked up-regulation of MAP kinase kinase kinase 8 (MAP3K8) and interleukin-1 beta (IL1B) [2-fold to >35-fold, and 4-fold to >50-fold, respectively]. We also observed consistent up-regulation of dual specificity phosphatase 5 and 6, growth arrest and DNA-damage-inducible alpha and beta, nuclear factor kappa-B subunit 1, Jun oncogene, fibroblast growth factor 1, and platelet-derived growth factor alpha. Our data support MAP3K8-induced activation of different MAPK signaling pathways in response to different profiles of shear stress, possibly as a consequence of shear-induced IL1B expression."

"IL-1 promotes a 10-fold increase in the induction of MAP3K8, a MAP kinase kinase kinase capable of acting on each of the ERK1/2, JNK and p38 signaling pathways."

" In response to 1, 5 and 10 dyn/cm2 shear stress we found pronounced up-regulation of interleukin-1 beta (IL1B) [24.2-, 15.5- and 11.6-fold, respectively] and MAP kinase kinase kinase 8 (MAP3K8, aka Cot/Tpl2; 6.6-, 8.6- and 13.5-fold, respectively"

"a roughly similar number of genes (450–700) were differentially expressed in response to each shear stress magnitude (1, 5 and 10 dyn/cm2) and duration (10 min, 1 and 24 h), although a 24 h duration resulted in over 1500 differentially expressed genes (2-h time point). In all cases, 55–60% of the genes were up-regulated at the 2 h time point, whilst after 24 h approximately 60% were down-regulated. "<-thus you likely don't want to load for over two hours.

"the most up-regulated gene was prostaglandin endoperoxide synthase 2 (PTGS2, aka COX2) [76-, 38- and 74-fold for 1, 5 and 10 dyn/cm2, respectively]"

Frequency-dependent enhancement of bone formation in murine tibiae and femora with knee loading.

"The left knee of C57/BL/6 [female 14 week old] mice was loaded with 0.5 N force at 5, 10, or 15 Hz for 3 min/day for 3 consecutive days"

"Compared with the sham-loading control, for instance, the cross-sectional cortical area was elevated maximally at 5 Hz in the tibia, whereas the most significant increase was observed at 15 Hz in the femur. Furthermore, mineralizing surface, mineral apposition rate, and bone formation rate were the highest at 5 Hz in the tibia (2.0-, 1.4-, and 2.7 fold, respectively) and 15 Hz in the femur (1.5-, 1.2-, and 1.8 fold, respectively). We observed that the tibia had a lower bone mineral density with more porous microstructures than the femur."<-this difference is interesting.  Maybe the higher BMD the more frequency needed to induce bone formation(and length increase).

"oscillatory alteration of intramedullary pressure in the femur was observed in response to sinusoidal loading with knee loading. Taken together, knee loading appears to affect motion of interstitial fluid as well as medullary fluid."

"Porosity is directly linked to the size of osteocyte population, which influences activities in bone remodeling. The relationship between osteocyte density and bone formation rate varies depending on skeletal site and developmental history. In human cancellous bone the inverse relationship between osteocyte density and bone formation rate was reported."

Monday, July 11, 2011

Fluid flow: LSJL v osteocytes & osteoblasts v chondrocytes

Since LSJL samples likely included osteocytes in the gene expression analysis. It should be useful to know which genetic upregulation is osteocyte specific.

Pulsating fluid flow modulates gene expression of proteins involved in Wnt signaling pathways in osteocytes.

"MC3T3-E1 osteoblasts were studied as a positive control for the MLO-Y4 osteocyte response to mechanical loading. MLO-Y4 osteocytes and MC3T3-E1 osteoblasts were submitted to 1-h PFF (0.7 +/- 0.3 Pa, 5 Hz), and postincubated (PI) without PFF for 0.5-3 h. Gene expression of proteins related to the Wnt canonical and noncanonical pathways were studied using real-time polymerase chain reaction (PCR). In MLO-Y4 osteocytes, PFF upregulated gene expression of Wnt3a, c-jun, connexin 43, and CD44 at 1-3-h PI. In MC3T3-E1 osteoblasts, PFF downregulated gene expression of Wnt5a and c-jun at 0.5-3-h PI. In MLO-Y4 osteocytes, gene expression of PFF-induced Wnt target genes was suppressed by the Wnt antagonist sFRP4, suggesting that loading activates the Wnt canonical pathway through functional Wnt production. The NO inhibitor L-NAME suppressed the effect of PFF on gene expression of Wnt target genes, suggesting that NO might play a role in PFF-induced Wnt production. The response to PFF differed in MC3T3-E1 osteoblasts."

"The Wnt canonical pathway is activated when a Wnt molecule binds to the cell surface receptor complexes consisting of human lowdensity lipoprotein (LDL) receptor-related protein 5/6 (LRP5/6) and frizzled transmembrane proteins (Fzd)"<-This leads to increased Beta-catenin levels.

"Messenger RNA expression of Wnt3a and the Wnt antagonist SFRP4 was observed in both osteocytes and osteoblasts. Wnt5a gene expression was quantifiable in MC3T3-E1 osteoblasts, but not in MLO-Y4 osteocytes."

"PFF significantly increased NO production at 5 min in MLO-Y4 osteocytes by 4.6-fold, and in MC3T3-E1 osteoblasts by 3.4-fold. The stimulatory effect continued up to 60 min in both cell types"

Voltage profile generation for simultaneous multi-protein detection in western blot analysis

"Protein samples were harvested from MC3T3 osteoblast like cells. Cells were cultured on collagen coated glass slides in MEM medium containing 10% fetal bovine serum and antibiotics. At 80% confluence, cells were serum starved for 12 h, and they were subjected to uni- form flow shear stress at 10 dyn/cm2 for 1 h"

Akt signaling increased in osteoblasts between 0-40 minutes of fluid shear stress.  Flow dramatically increased p-38, p-ERK, and slightly increased p-Akt.  Thus some of the increase in ERK-p and p-38 detection in LSJL may be due to it's stimulation in osteoblasts but not so much for Akt.

Differential Activation and Inhibition of RhoA by Fluid Flow Induced Shear Stress in Chondrocytes.

"Activities of GTPase RhoA in chondrocytes are dependent on intensities of flow induced shear stress. RhoA activities can be either elevated or reduced by selecting different levels of shear stress intensities. C28/I2 chondrocytes have increased RhoA activities in response to high shear stress (10 or 20 dyn/cm(2) ), whereas a decrease in activity was seen with an intermediate shear stress of 5 dyn/cm(2). No changes were seen under low shear stress (2 dyn/cm(2) ). The observed 2-level switch of RhoA activities is closely linked to the shear stress-induced alterations in actin cytoskeleton and traction forces. In the presence of constitutively active RhoA (RhoA-V14), intermediate shear stress suppressed RhoA activities, while high shear stress failed to activate them. In chondrocytes, expression of various metalloproteinases is, in part, regulated by shear and normal stresses through a network of GTPases."

"Moderate mechanical loading, for instance, is reported to decrease proteolytic activities of degenerative enzymes in the articular cartilage, while excessive loading may lead to an increase in expression of matrix metalloproteinases"<-This isn't necessarily a bad thing as some MMP's like MMP13 are associated with endochondral ossification.

"Rho-associated kinase (ROCK), promotes the assembly of actin cytoskeleton and phosphorylation of myosin light chains. By regulating intracellular tension through the cytoskeleton, this RhoA-ROCK signaling alters cell shape, and migration patterns as well as cellular differentiation"

"To test the role of intracellular tension in shear stress-induced RhoA activity, we used ML-7 to inhibit myosin light chain kinase or blebbistatin (Bleb) to inhibit non-muscle myosin II. Pretreating with ML-7 (25 μM) or Bleb (50 μM) also prevented shear stress-induced RhoA activation and inhibition at corresponding shear stress levels"

"myosin II-dependent, tensed actin cytoskeleton is necessary for selective RhoA regulation by shear stress regardless of the shear stress magnitude."

"Chondrocytes are in general rich in cortical actin but poor in cytosolic stress fibers. When they dedifferentiate to fibroblast-like cells, they are reported to develop stress fibers. Shapes and differentiation states of chondrocytes are regulated differentially by intermediate and high shear stresses"

Rac1 and Cdc42 GTPases regulate shear stress-driven β-catenin signaling in osteoblasts.

"Herein we investigated the molecular mechanisms underlying oscillatory shear stress-induced TCF/LEF activity in MC3T3-E1 osteoblast cells using live cell imaging. We employed fluorescence resonance energy transfer (FRET)-based and green fluorescent protein (GFP)-based biosensors, which allowed us to monitor signal transduction in living cells in real time. Oscillatory (1 Hz) shear stress (10 dynes/cm2) increased TCF/LEF activity and stimulated translocation of β-catenin to the nucleus with the distinct activity patterns of Rac1 and Cdc42. The shear stress-induced TCF/LEF activity was blocked by the inhibition of Rac1 and Cdc42 with their dominant negative mutants or selective drugs, but not by a dominant negative mutant of RhoA. In contrast, constitutively active Rac1 and Cdc42 mutants caused a significant enhancement of TCF/LEF activity. Moreover, activation of Rac1 and Cdc42 increased the basal level of TCF/LEF activity, while their inhibition decreased the basal level. Interestingly, disruption of cytoskeletal structures or inhibition of myosin activity did not significantly affect shear stress-induced TCF/LEF activity. Although Rac1 is reported to be involved in β-catenin in cancer cells, the involvement of Cdc42 in β-catenin signaling in osteoblasts has not been identified."

" β-catenin in the cytoplasm is stabilized by the inactivation of a destruction complex such as axin and GSK3β (glycogen synthase kinase 3β) and translocated to the nucleus. The β-catenin in the nucleus associates with TCF/LEF (T-cell factor/lymphocyte enhancing factor) transcription factors, leading to the activation of TCF/LEF and induction of expression of Wnt target genes"

That was a Yokota study.  So Beta-Catenin is likely stabilized in the osteoblasts by LSJL.  How that can apply to height increase is unclear.

Another Yokota study:

RhoA GTPase interacts with beta-catenin signaling in clinorotated osteoblasts.

"Does unloading suppress an activation level of RhoA GTPase and β-catenin signaling in osteoblasts? If yes, what is the role of RhoA GTPase and actin filaments in osteoblasts in regulating β-catenin signaling? Using a fluorescence resonance energy transfer (FRET) technique with a biosensor for RhoA together with a fluorescent T cell factor/lymphoid enhancer factor (TCF/LEF) reporter, we examined the effects of clinostat-driven[microgravity simulator] simulated unloading. Both RhoA activity and TCF/LEF activity were downregulated by unloading. Reduction in RhoA activity was correlated to a decrease in cytoskeletal organization of actin filaments. Inhibition of β-catenin signaling blocked unloading-induced RhoA suppression, and dominant negative RhoA inhibited TCF/LEF suppression. On the other hand, a constitutively active RhoA enhanced unloading-induced reduction of TCF/LEF activity. The TCF/LEF suppression by unloading was enhanced by co-culture with osteocytes, but it was independent on the organization of actin filaments, myosin II activity, or a myosin light chain kinase. Collectively, the results suggest that β-catenin signaling is required for unloading-driven regulation of RhoA, and RhoA, but not actin cytoskeleton or intracellular tension, mediates the responsiveness of β-catenin signaling to unloading."

"simulated unloading by clinorotation reduces β-catenin signaling activity of MC3T3-E1 cells"

"RhoA is activated by fluid flow and its activation mediates fluid flow-induced PI3K and MAPK signaling"

Fluid flow in the osteocyte mechanical environment: a fluid-structure interaction approach.

"Osteocytes are an elastic cellular structure that deforms in response to the external fluid flow imposed by mechanical loading. The objective of this study is to employ fluid-structure interaction (FSI) modelling to investigate the complex mechanical environment of osteocytes in vivo. By simulating loading levels representative of vigorous physiological activity (3000mupu compression and 300 Pa pressure gradient), we predict average interstitial fluid velocities(60.5mupu/s and average maximum shear stresses  surrounding osteocytes in vivo. Interestingly, these values occur in the canaliculi around the osteocyte cell processes and are within the range of stimuli known to stimulate osteogenic responses by osteoblastic cells in vitro. The greatest mechanical stimulation of the osteocyte occurs in the cell processes, the most mechanosensitive area of the cell."

"Loading the bone matrix surrounding osteocytes generates a pressure differential that drives flow of interstitial fluid within the lacunar–canalicular network. The fluid flow generates a shear stress on the osteocyte cell membrane"

"pressure gradients within individual canaliculi [can be] as high as 1 Pa/nm, the equivalent of an approximately 800 Pa pressure gradient along the length of a single canaliculus"

"within the range of 0.1–2.2 Pa, which has been shown in cell culture studies of osteoblastic cells to result in increased nitric oxide (NO), prostaglandin ( PGE 2) and osteopontin production"<-These chemicals can affect MSCs and chondrocytes.  Calcium signaling also increases which too can impact MSCs.

Tuesday, July 5, 2011

How LSJL deforms the bone


Measurement of Strain Distributions in Mouse Femora with 3D-Digital Speckle Pattern Interferometry

"During measurements, we applied 5 steps of loading in 10 seconds interval with an increment of 11.8 V to the piezoelectric actuator. This voltage step generated a step force of 0.2 N, and the total force applied to the epiphysis was 1 N"


"strain in the femoral diaphysis is significantly smaller (nearly zero) than that in the distal epiphysis at the loading site"


Thursday, February 17, 2011

What's the current status of Lateral Synovial Joint Loading research?

Since the publication of Lengthening of Mouse Hindlimbs with Joint Loading, there hasn't been papers directly related to LSJL likely due to CH Turner's death.  Are the scientists working on Lateral Joint Loading or do we have to rely on our own?

Here's what Stuart J. Warden's(wrote a paper related to LSJL and is CH Turner's mentee) working on:

NIH-NIAMS (R15 AR056858)
Long-term skeletal effects of exercise during growth
Role: Principal investigator (1.5 academic months)
$231,000

NIH-NIAMS (R01 AR052018)
The function of neurotransmitters in bone biology[should be interesting but not related to LSJL]
Role: Subcontract co-investigator (3 summer months) [PI-Bliziotes (Oregon Health and Science University)]
$1,480,725 (IU subcontract $608,000)

National Space Biomedical Research Institute (MA01604)
Extent, causes, and countermeasures of impaired fracture healing in hypogravity
Role: Subcontract principal investigator (1 academic month) [PI-Midura (Cleveland Clinic)]
$1,789,968 (IU subcontract $338,472)

Department of Defense
Secreted Wnt antagonists in disuse-induced osteoporosis
Role: Co-investigator (1 academic month) [PI-Robling (IU School of Medicine)]
$1,062,982

NIH-NICHD (R01 HD057126)
Supplemental vitamin D and functional outcomes in early adolescence[this should be very interesting given that the cyp27b1 enzyme related to Vitamin D[it converts Vitamin D to the active metabolite] has possible height shortening effects]
Role: Subcontract co-investigator (0.5 academic months) [PI-Lewis (University of Georgia)]
$1,076,127

Hiroki Yokota seems to still be working on it, in his research goals:  He states that his goals are:

"Analysis of molecular and cellular mechanisms in bone remodeling
Development of mechanical loading devices for strengthening bone[C-class clamps?]
Development of therapeutic agents for enhancing bone formation[chemical methods likely]"

Hiroki Yokota seems to be focused now on developing some sort of grow taller pill possibly:


"Hiroki Yokota, a professor of biomedical engineering at IUPUI developed a drug that stimulates bone growth. Normally a technology transfer might have occurred, but we were able to leverage a lot of resources through Indiana University (IU). Indiana Clinical and Translational Sciences Institute (CTSI) resources allowed us to hire a private contractor to create a new formulation that was better. Lilly scientists were invited to provide input on what they would do next. Kelley School of Business life sciences students helped develop a marketing plan that identified a potential market for broken bones in addition to osteoporosis. As a result, we hope to use this model to speed the process from the research bench to the bedside."<-this pill may upregulate TGF-Beta and may help people grow taller.  This is definitely part of his therapeutic agents.


Here's another article about it:  It's apparently a new compound.  Here's a paper discussing the drug:  Salibrunal activates genes involved in anabolic processes in bones <-these anabolic processes can play a role in helping you grow taller.  Salubrinal inhibits GADD34-PP1 phosphatase which can cause cell death.  The timeline for the drug estimates to be about 8 years.  Here's another article about Salubrinal.


"I was originally exploring mechanical stimulation, which is similar to exercise, to strengthen bones. But by studying these mechanisms, I came across a molecular pathway that became the beginning of this discovery."<-He discovered the pathways behind salubrinal while researching LSJL thus salubrinal may be related to the pathways involved in LSJL.


"Older populations are increasingly affected by weakened and broken bones as aging cells are no longer able to produce sufficient levels of collagen, the protein from which bones derive their strength. Salubrinal prevents this cellular decline by strengthening the body’s “protein-producing machinery,” which creates collagen and keeps bones strong."<-Type II collagen helps you grow taller so perhaps salubrinal could have height increase affects as well.


"the cells just enjoy the body’s rescue response without really experiencing any new negative pressure"<-So Salubrinal is anabolic.

Here's more about Salubrinal:


Salubrinal promotes healing of surgical wounds in rat femurs.


"Phosphorylation of eukaryotic initiation factor 2α (eIF2α), transiently activated by various cellular stresses, is known to alleviate stress-induced cellular damage. Here, we addressed a question: does elevation of eIF2α phosphorylation by salubrinal (a pharmacological inhibitor of eIF2α dephosphorylation) enhance healing of bone wounds? We hypothesized that salubrinal would accelerate a closure of surgically generated bone holes by modifying expression of stress-sensitive genes. To examine this hypothesis, we employed a rat wound model. Surgical wounds were generated on anterior and posterior femoral cortexes, and salubrinal was locally administered on the anterior side. The results showed that, compared to a contralateral control, the size of surgical wounds was reduced by 10.8 % (day 10) and 18.0 % (day 20) on the anterior side (both p < 0.001), and 4.1 % (day 10; p < 0.05) and 11.1 % (day 20; p < 0.001) on the posterior side. In addition, salubrinal locally elevated cortical thickness and increased BMD and BMC. Pharmacokinetic analysis revealed that subcutaneous injection of salubrinal transiently increased its concentration in plasma followed by a rapid decrease within 24 h, and its half-life in plasma was 1.2 h. Salubrinal altered the phosphorylation level of eIF2α as well as the mRNA levels of ATF3, ATF4, and CHOP, and suppressed cell death induced by stress to the endoplasmic reticulum. In summary, the results herein demonstrate that subcutaneous administration of salubrinal accelerates healing of surgically generated bone holes through the modulation of eIF2α phosphorylation."


<-we need to see if increasing mRNA levels of ATF3, ATF4, and CHOP will increase height.  This study suggested that joint loading reduced phosphorylation of EIF2alpha.  So Salubrinal does not operate in the same way as joint loading.  But joint loading increased mRNA levels of ATF3.  Individuals deficient in ATF4 show reduced height.  ATF3 is linked to chondrocyte development as suggested in the study.


"To alleviate cellular injury or initiate apoptotic cell death, cells induce an integrated stress response (ISR). During ISR, phosphorylation of the alpha subunit of eukaryotic initiation factor 2α (eIF2α) is activated, and this ISR-driven phosphorylation blocks an exchange process of eukaryotic translation initiation factor 2B from GDP-bound eIF2 to GTP-bound eIF2. Consequently, the global translation-initiation is suppressed except for a group of specific genes whose expression is presumably crucial for an adaptive response for survival. Thus, the modulation of a phosphorylated level of eIF2α potentially alters the fate of damaged tissues."<-so manipulating phosphorylation of EIF2alpha alters fate of damaged tissues so it may alter growth(there is always stress to cells even in healthy growth plates).  Note though that chondrocyte apoptosis may play a vital role in height growth.


"First, in response to 10 μM salubrinal, an increase in the phosphorylation level of eIF2α (eIF2α-p) was observed at 3 and 5 h. Second, this increase in eIF2α-p was dosage dependent for the administration of 10 and 50 μM salubrinal on days 1 and 2"

"The rationale for administration of salubrinal is that phosphorylation of eIF2α is cytoprotective during ISR, and salubrinal is used to protect cells from ISR and apoptosis"<-But again apoptosis may be important to growth plates.

"Using mice without bone wounds, that a salubrinal-treated femur had a higher BMD than a contralateral control femur and a vehicle control femur. These observations together with pharmacokinetic results indicated local effects of salubrinal, when applied subcutaneously. However, we also observed a gradual increase in body weight of the salubrinal-treated rats compared to vehicle controls, suggesting a possibility of a systemic side effect"<-could the increase in body weight be due to bone length?

The study: Reactive oxygen species and p38 MAPK regulate Bax translocation and calcium redistribution in salubrinal-induced apoptosis of EBV-transformed B cells states that salubrinal increased Ca2+ in B cells and Ca2+ uptake in mitochondria although this does not indicate that the same would occur in MSCs.  The general mechanism of action for salubrinal is described as "phosphorylated eIF2α-mediated survival has been known to lead to cap-dependent protein translation inhibition, activation of PI3K, induction of NF-kB, degradation of p53, and decreased load of nascent proteins in the ER, whereas phosphorylated eIF2α-mediated cell death has been known to decrease cyclin D1 translation and induce the ATF4-CHOP pathway"


He's in close proximity with Dr. Plopper who can help him with LSJL:


"Differentiation of human mesenchymal stem cells (hMSC) plated in/on defined ECM proteins: We are defining the effect of ECM contact on human mesenchymal stem cell differentiation. Our hypothesis is that contact with distinct ECM proteins stimulates specific signaling pathways that ultimately control the differentiation of these cells into bone-, cartilage-, or fat-producing cells."


This is key to us, as ECM proteins are one thing that are expressed during puberty but not post fusion(they can be induced though). Dr. Plopper even touches a course on ECM at Purdue.  Weeks 5-10 could help us grow taller, especially week 9 is about the ECM-cytoskeleton connection.
As could Dr. Kotha:


"Dr Kotha’s group studies the role of mechanical loading on damage and repair to bone at multiple length scales. They characterize how mineral and organic in bone support its deformation as load is applied. When this is combined with novel non-invasive ultrasound based technologies[Dr. Kotha could help us with LIPUS] being developed, the overall goal is to make devices that can be used to monitor the risk of bone failure at specific sites. They also evaluate how cells sense deformation of bone and what molecular pathways are activated in response to loading."


So maybe the reason why there haven't been LSJL studies lately is that Yokota, Kotha, and Plopper are working on something big.  If you want to go to the school of growing taller you should go to department of biomedical engineering at Rensselaer.


Here's what Ping Zhang is working on:

"Fabrication and application of unique loading devices."<-Again C-class clamp?

"Anatomical, physiological and mechanical characterization of bones and joints under mechanical loading[lateral joint loading] Identification of cellular and molecular mechanisms involved in mechanotransduction of bone and joint cells."